CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,205,365 | +1377.5% | 566,700 | +392.7% | 1.48% | +1802.6% |
| Q3 2021 | $420,000 | -41.4% | 115,015 | -17.8% | 0.08% | -69.9% |
| Q3 2019 | $717,000 | -90.2% | 140,000 | -74.5% | 0.26% | -87.2% |
| Q1 2019 | $7,304,000 | +28.0% | 550,000 | -24.1% | 2.02% | -5.0% |
| Q4 2018 | $5,705,000 | -26.2% | 725,000 | +3.9% | 2.13% | +8.2% |
| Q3 2018 | $7,735,000 | -17.4% | 698,100 | +0.1% | 1.97% | -18.8% |
| Q2 2018 | $9,360,000 | +8.4% | 697,500 | +4.9% | 2.42% | -1.9% |
| Q1 2018 | $8,638,000 | +41.2% | 665,000 | 0.0% | 2.47% | +26.1% |
| Q4 2017 | $6,118,000 | +14.2% | 665,000 | 0.0% | 1.96% | +3.4% |
| Q3 2017 | $5,356,000 | – | 665,000 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |